Surveillance and outbreak reports Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007 15 by I Devaux, D Manissero, K Fernandez de la Hoz, K Kremer, D van Soolingen, on behalf of the EuroTB network Analysis of tuberculosis ...
A Amato-gauci +24 more
core
Extensively drug-resistant tuberculosis (XDR-TB) is a public health concern as drug resistance is outpacing the drug development pipeline. Alternative immunotherapeutic approaches are needed.
Rolanda Londt +7 more
doaj +1 more source
Protocol for a systematic review of long-term physical sequelae and financial burden of multidrug-resistant and extensively drug-resistant tuberculosis. [PDF]
Akalu TY +3 more
europepmc +1 more source
The Reductionist Conundrum of an "Updated" Definition of Extensively Drug-Resistant Tuberculosis. [PDF]
Mitnick CD, Furin JJ, Hewison C.
europepmc +1 more source
Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era. [PDF]
Utpat KV, Rajpurohit R, Desai U.
europepmc +1 more source
Extensively drug-resistant tuberculosis (XDR-TB) among health care workers in South Africa [PDF]
Adams, Shahieda +10 more
core +1 more source
Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa. [PDF]
Sy KTL +9 more
europepmc +1 more source
Adjusting to a new home: Mycobacterium tuberculosis gene expression in response to an intracellular lifestyle. [PDF]
Mycobacterium tuberculosis remains the most significant single species of bacteria causing disease in mankind. The ability of M. tuberculosis to survive and replicate within host macrophages is a pivotal step in its pathogenesis.
Stokes, Richard W, Waddell, Simon J
core
Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis. [PDF]
Fekadu G, Yao J, You JHS.
europepmc +1 more source
Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis. [PDF]
Mulder C +15 more
europepmc +1 more source

